ClinicalTrials.gg
Not yet recruitingNCT07777679VR-CBTUpdated Aug 24, 2026

VR-Cognitive Behavioral Therapy Prehabilitation for Spinal Deformity Surgery

An interventional study of Virtual Reality-Based CBT Prehabilitation (VR-CBT) and CBT Prehabilitation without Virtual Reality in Degenerative Spine Disease and Spinal Stenosis Lumbar, sponsored by University of California, Irvine. Not yet recruiting at 2 sites in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by University of California, Irvine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether a virtual reality-based cognitive behavioral therapy (VR-CBT) prehabilitation program can improve recovery and quality of life for adults undergoing elective spine surgery. The main questions it aims to answer are:

Does participating in an 8-week VR-CBT prehabilitation program before surgery improve physical function and pain-related outcomes at 12 months after surgery?

Does VR-CBT prehabilitation reduce postoperative anxiety, depression, and pain interference compared with usual preoperative care?

Researchers will compare participants who receive the VR-CBT prehabilitation program plus usual care to participants who receive usual preoperative care alone to see if the VR-CBT program leads to better recovery and patient-reported outcomes.

Participants will:

Use a VR headset at home to complete structured CBT-based prehabilitation sessions over 8 weeks before surgery.

Attend routine clinic visits and complete questionnaires about pain, function, mood, and quality of life before surgery and through 12 months after surgery.

Allow the research team to review their medical records for information about surgery, complications, and postoperative recovery.

Read the detailed description

Elective spine surgery is commonly performed to address pain, neurologic symptoms, and functional limitations, yet many patients experience persistent postoperative pain, anxiety, and impaired quality of life despite technically successful procedures. Psychological factors such as catastrophizing, fear of movement, and low self-efficacy are strongly associated with poorer recovery trajectories after spine surgery. Virtual reality-based cognitive behavioral therapy (VR-CBT) is an emerging, scalable approach that can deliver structured coping skills training and exposure-based exercises in an immersive environment, potentially enhancing preoperative preparedness and postoperative recovery.

This multi-site, interventional clinical trial will evaluate two formats of a CBT-based prehabilitation program for adults undergoing elective spine surgery at UC Irvine and Hoag Memorial Hospital Presbyterian. Each participant's study involvement lasts approximately 12 months and includes an 8-week preoperative prehabilitation period followed by postoperative follow-up through 12 months after surgery. The primary objective is to determine whether delivering spine-focused CBT prehabilitation using a virtual reality platform (VR-CBT) leads to better patient-reported outcomes and functional recovery at 12 months after surgery compared with the same CBT prehabilitation delivered without virtual reality. Secondary objectives include examining the effects of VR-CBT versus non-VR CBT on pain intensity, pain interference, mood symptoms (e.g., anxiety and depression), health-related quality of life, and patient satisfaction with care.

Eligible patients scheduled for qualifying spine procedures at participating sites will be approached in the clinic and, after providing informed consent, enrolled and assigned either to receive CBT prehabilitation delivered with VR-based exposure (VR-CBT) or to receive the same CBT prehabilitation without VR (standard CBT), in both cases alongside usual perioperative clinical care. The VR-CBT program consists of multiple home-based sessions delivered via a virtual reality headset and software platform over the 8-week preoperative window. Session content focuses on psychoeducation about surgery and recovery, cognitive restructuring, relaxation and mindfulness skills, graded exposure to movement and pain-related cues, and rehearsal of adaptive coping strategies in immersive VR environments. In the comparator arm, participants receive the same CBT content through non-VR delivery methods (e.g., in-person or video-based sessions and written/online materials) without access to VR technology.

Research-specific assessment visits of approximately 45-60 minutes are aligned whenever possible with routine clinical visits at each site to minimize participant burden. Participants complete validated questionnaires assessing pain, function, and psychosocial factors at baseline (before starting CBT with or without VR), after the prehabilitation period, and at multiple postoperative time points through 12 months. Additional data are abstracted from the electronic medical record, including details of the surgical procedure, perioperative complications, healthcare utilization, and opioid prescriptions. These data will be used to explore whether VR-CBT prehabilitation influences not only patient-reported outcomes but also clinical recovery metrics and resource use across sites.

Safety monitoring is conducted under the oversight of the Institutional Review Boards at each participating institution, including UC Irvine (ZotIRB). Adverse events, including unexpected psychological distress or intolerance of VR use, are recorded throughout study participation and managed according to institutional policies. Because this is a behavioral intervention study that does not involve an FDA-regulated drug or device, no Investigational New Drug (IND) application or Investigational Device Exemption (IDE) is required, and an independent data monitoring committee is not convened. Results from this trial are intended to inform whether VR-CBT prehabilitation is a feasible and potentially effective strategy to improve recovery and long-term outcomes for patients undergoing spine surgery, and to guide the design of future larger-scale studies.

02

Conditions studied

  • Degenerative Spine Disease
  • Spinal Stenosis Lumbar

Browse trials for

Keywords

  • Virtual reality-based cognitive behavioral therapy
  • Patient-reported outcomes
  • Spine surgery prehabilitation
03

In context

Spinal Stenosis

458 studies on the registry are indexed under Spinal Stenosis; 105 are open to participants now.

This study's planned enrollment of 80 is close to the median of 80 across 281 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

University of California, Irvine is the lead sponsor of 476 studies on the registry; 98 are open to participants now.

Of its 41 completed or terminated interventional studies of FDA-regulated products, 30 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults between 18 and 75 years old.
  • Diagnosis of thoracolumbar adult spinal deformity (ASD), including but not limited to adult scoliosis, kyphosis, or spondylolisthesis, confirmed radiographically using SRS-Schwab classification criteria.
  • Scheduled for elective spinal surgery involving fusion of more than four spinal levels.
  • Moderate to severe chronic pain, assessed using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS).
  • Ability to participate in an 8-week preoperative prehabilitation program.
  • Adequate cognitive functioning and English language skills to engage in CBT or VR-CBT treatments.
  • Ability to provide written and adhere to study procedures and follow-up visits.

Exclusion criteria

Exclusion Criteria

  • Neurological conditions that significantly impact cognition or mobility.
  • Active spinal infection, , or significant spinal trauma.
  • Unmanaged medical conditions that could affect participation in the study.
  • Pregnancy or plans to become pregnant during the study period.
  • Severe visual impairment, claustrophobia, or other conditions that prevent safe use of VR technology.
  • Cognitive impairment preventing adherence to study procedures.
  • History of non-compliance with medical treatment or failure to adhere to study visits and follow-up.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    CBT Prehabilitation with Virtual Reality Exposure

    Participants receive a spine-focused CBT prehabilitation program delivered using a virtual reality platform (VR-CBT) in addition to usual perioperative clinical care. The 8-week preoperative program includes home-based VR sessions targeting psychoeducation about surgery and recovery, cognitive restructuring, relaxation and mindfulness, and graded exposure to movement and pain-related cues in immersive VR environments

    Behavioral: Virtual Reality-Based CBT Prehabilitation (VR-CBT)

  • Active comparator
    CBT Prehabilitation without Virtual Reality

    Participants receive the same spine-focused CBT prehabilitation content delivered without VR (standard CBT sessions/materials) in addition to usual perioperative clinical care. The 8-week preoperative program uses non-VR delivery methods (e.g., in-person or video-based sessions and written/online materials) covering psychoeducation, cognitive restructuring, relaxation and mindfulness, and graded exposure to movement and pain-related cues without VR technology.

    Behavioral: CBT Prehabilitation without Virtual Reality

Interventions

  • BehavioralVirtual Reality-Based CBT Prehabilitation (VR-CBT)

    A spine-focused cognitive behavioral therapy (CBT) prehabilitation program delivered using a virtual reality platform. Over 8 weeks before surgery, participants complete home-based VR sessions via a headset and software that provide psychoeducation about surgery and recovery, cognitive restructuring exercises, relaxation and mindfulness training, and graded exposure to movement and pain-related cues in immersive virtual environments. This intervention is administered in addition to usual perioperative clinical care.

  • BehavioralCBT Prehabilitation without Virtual Reality

    A spine-focused CBT prehabilitation program delivered without VR. Over 8 weeks before surgery, participants receive the same CBT content using non-VR methods covering psychoeducation about surgery and recovery, cognitive restructuring, relaxation and mindfulness, and graded exposure to movement and pain-related cues. This intervention is administered in addition to usual perioperative clinical care.

06

What researchers measure

Primary outcomes

  1. Change in Oswestry Disability Index (ODI) Score from Baseline to 12 Months After Surgery

    The Oswestry Disability Index (ODI) is a patient-reported measure of back pain-related disability with scores ranging from 0 to 100, where higher scores indicate greater disability. Change is calculated as ODI score at 12 months after surgery minus the baseline (preoperative) ODI score.

    Time frame: Baseline (preoperative) and 12 months after surgery

  2. Change in pain intensity (VAS/NRS) from baseline to 12 months after surgery

    Pain intensity will be assessed using a 0-10 Visual Analog Scale (VAS) or Numeric Rating Scale (NRS), where higher scores indicate greater pain. Change in pain intensity will be calculated as the score at 12 months after surgery minus the baseline (preoperative) score

    Time frame: Baseline (preoperative) and 12 months after surgery

  3. Change in functional mobility (Timed Up and Go and Functional Gait Assessment) from baseline to 12 months after surgery

    Functional mobility will be measured using the Timed Up and Go (TUG) test and the Functional Gait Assessment (FGA). TUG records the time in seconds required for a patient to stand from a chair, walk 3 meters, turn, walk back, and sit; longer times indicate worse mobility. FGA is a multi-item clinician-rated scale of dynamic gait stability with scores typically ranging from 0 to 30, where higher scores indicate better gait function. Change in functional mobility will be calculated as TUG time and FGA score at 12 months after surgery compared with baseline (preoperative) values.

    Time frame: Baseline (preoperative) and 12 months after surgery.

Secondary outcomes

  1. Change in psychological distress (Pain Catastrophizing Scale) from baseline to 12 months after surgery

    Psychological distress related to pain will be measured using the Pain Catastrophizing Scale (PCS), which assesses rumination, magnification, and helplessness about pain. PCS total scores (higher scores indicating greater catastrophizing) at 12 months after surgery will be compared with baseline scores to quantify change.

    Time frame: Baseline (preoperative) and 12 months after surgery.

  2. Change in fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire) from baseline to 12 months after surgery

    Fear-avoidant behaviors will be assessed using the Fear-Avoidance Beliefs Questionnaire (FABQ), which evaluates fear-based beliefs about physical activity and work in relation to pain. FABQ subscale and total scores (higher scores indicating greater fear-avoidance) at 12 months after surgery will be compared with baseline scores.

    Time frame: Baseline (preoperative) and 12 months after surgery

  3. Change in postural awareness score from baseline to 12 months after surgery

    Postural awareness will be assessed using a study-specific postural awareness measure (e.g., questionnaire or rating scale) designed to capture patients' awareness of spinal alignment and posture during daily activities. Higher scores will reflect greater postural awareness. Change in postural awareness will be calculated as the score at 12 months after surgery compared with baseline.

    Time frame: Baseline (preoperative) and 12 months after surgery.

  4. Postoperative opioid use through 12 months after surgery

    Opioid use will be quantified using prescription and medication-use data abstracted from the electronic medical record. Outcomes will include total opioid consumption expressed in morphine milligram equivalents (MME) and patterns of opioid prescribing over the postoperative period.

    Time frame: From hospital discharge through 12 months after surgery.

  5. Postoperative functional recovery through 12 months after surgery

    Postoperative functional recovery will be evaluated using a composite of functional mobility assessments (Timed Up and Go, Functional Gait Assessment) and patient-reported functional measures specified in the full protocol. Recovery will be characterized by the magnitude and trajectory of improvement in these measures over the 12-month postoperative period.

    Time frame: Baseline (preoperative) and repeated postoperative assessments through 12 months after surgery.

07

Study locations

2 sites
  • UCI Health - Orthopaedic Spine Center (Wen Center for Advanced Care)
    Irvine, California 92617, United States
  • Hoag Memorial Hospital Presbyterian (Hoag Hospital Newport Beach)
    Newport Beach, California 92663, United States
08

References and documents

Publications

  • Feng H, Li C, Liu J, Wang L, Ma J, Li G, Gan L, Shang X, Wu Z. Virtual Reality Rehabilitation Versus Conventional Physical Therapy for Improving Balance and Gait in Parkinson's Disease Patients: A Randomized Controlled Trial. Med Sci Monit. 2019 Jun 5;25:4186-4192. doi: 10.12659/MSM.916455. PubMed 31165721 ↗
  • Montgomery EY, Pernik MN, Johnson ZD, Dosselman LJ, Christian ZK, Deme PR, Adeyemo EA, Barrie U, Badejo O, Stewart NA, Uttarkar R, Adogwa O, Tecle NE, Aoun SG, Bagley CA. Perioperative Factors Associated With Chronic Opioid Use After Spine Surgery. Global Spine J. 2023 Jul;13(6):1450-1456. doi: 10.1177/21925682211035723. Epub 2021 Aug 20. PubMed 34414800 ↗
  • Li R, Li Y, Kong Y, Li H, Hu D, Fu C, Wei Q. Virtual Reality-Based Training in Chronic Low Back Pain: Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Med Internet Res. 2024 Feb 26;26:e45406. doi: 10.2196/45406. PubMed 38407948 ↗
  • Morone NE, Greco CM, Moore CG, Rollman BL, Lane B, Morrow LA, Glynn NW, Weiner DK. A Mind-Body Program for Older Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Intern Med. 2016 Mar;176(3):329-37. doi: 10.1001/jamainternmed.2015.8033. PubMed 26903081 ↗
  • Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007 Feb;30(1):77-94. doi: 10.1007/s10865-006-9085-0. Epub 2006 Dec 20. PubMed 17180640 ↗
  • Misterska E, Tomaszewski M, Gorski F, Gapsa J, Slysz A, Glowacki M. Assessing the Efficacy of Cognitive-Behavioral Therapy on Body Image in Adolescent Scoliosis Patients Using Virtual Reality. J Clin Med. 2024 Oct 26;13(21):6422. doi: 10.3390/jcm13216422. PubMed 39518561 ↗
  • Lee M, Jang S, Shin HK, Choi SW, Kim HT, Oh J, Kwon JH, Choi Y, Kang S, Back IS, Kim JK, Lee S, Seok JH. Virtual Reality-Based Cognitive Behavior Therapy for Major Depressive Disorder: An Alternative to Pharmacotherapy for Reducing Suicidality. Yonsei Med J. 2025 Jan;66(1):25-36. doi: 10.3349/ymj.2024.0002. PubMed 39742882 ↗
  • Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. NPJ Schizophr. 2021 Feb 12;7(1):9. doi: 10.1038/s41537-021-00139-2. PubMed 33580033 ↗
  • Brea-Gomez B, Torres-Sanchez I, Ortiz-Rubio A, Calvache-Mateo A, Cabrera-Martos I, Lopez-Lopez L, Valenza MC. Virtual Reality in the Treatment of Adults with Chronic Low Back Pain: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Int J Environ Res Public Health. 2021 Nov 11;18(22):11806. doi: 10.3390/ijerph182211806. PubMed 34831562 ↗
  • Goudman L, Jansen J, Billot M, Vets N, De Smedt A, Roulaud M, Rigoard P, Moens M. Virtual Reality Applications in Chronic Pain Management: Systematic Review and Meta-analysis. JMIR Serious Games. 2022 May 10;10(2):e34402. doi: 10.2196/34402. PubMed 35536641 ↗
  • Eubanks JE, Carlesso C, Sundaram M, Bejarano G, Smeets RJEM, Skolasky R, Vanushkina M, Turner R, Schneider MJ. Prehabilitation for spine surgery: A scoping review. PM R. 2023 Oct;15(10):1335-1350. doi: 10.1002/pmrj.12956. Epub 2023 Apr 3. PubMed 36730164 ↗
  • Strom J, Bjerrum MB, Nielsen CV, Thisted CN, Nielsen TL, Laursen M, Jorgensen LB. Anxiety and depression in spine surgery-a systematic integrative review. Spine J. 2018 Jul;18(7):1272-1285. doi: 10.1016/j.spinee.2018.03.017. Epub 2018 Apr 9. PubMed 29649613 ↗
  • Safaee MM, Ames CP, Smith JS. Epidemiology and Socioeconomic Trends in Adult Spinal Deformity Care. Neurosurgery. 2020 Jul 1;87(1):25-32. doi: 10.1093/neuros/nyz454. PubMed 31620794 ↗
  • Diebo BG, Shah NV, Boachie-Adjei O, Zhu F, Rothenfluh DA, Paulino CB, Schwab FJ, Lafage V. Adult spinal deformity. Lancet. 2019 Jul 13;394(10193):160-172. doi: 10.1016/S0140-6736(19)31125-0. Epub 2019 Jul 11. PubMed 31305254 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Nov 2028, 26 months later.

Of 105 non-industry interventional studies with no phase under Spinal Stenosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 26 months is below that.

Counting every sponsor, half of 123 studies reached it within 30 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2026
First posted
Aug 20, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Nov 28, 2028
CompletionEst.
Nov 28, 2028
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07777679
Responsible party
Michael Oh (Professor of Clinical Neurological Surgery, University of California, Irvine) — Principal investigator
First posted
Aug 20, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Nov 28, 2028 (estimated)
Completion
Nov 28, 2028 (estimated)
Last update
Aug 24, 2026

Study contacts

Micheal Y Oh, MD
Contact
ohm2@hs.uci.edu
714-456-7012
George H Habib, BS
Contact
ghabib0379@gmail.com
9096965362

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion